Latest News and Press Releases
Want to stay updated on the latest news?
-
Dublin, Dec. 10, 2025 (GLOBE NEWSWIRE) -- The "Preclinical Imaging Market Size, Share & Trends Analysis Report by Type (Modality, Reagents, and Service), Application (Drug Discovery &...
-
Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The "Global ADME Toxicology Testing Market - Technologies, Methods and Applications" has been added to ResearchAndMarkets.com's offering. The global ADME...
-
Austin, Oct. 15, 2025 (GLOBE NEWSWIRE) -- ADME Toxicology Testing Market Size & Growth Analysis According to SNS Insider, the global ADME Toxicology Testing Market was valued at USD 6.64...
-
Dublin, Sept. 30, 2025 (GLOBE NEWSWIRE) -- The "Specialty CROs Market Industry Trends and Global Forecasts to 2035 - Distribution by Target Therapeutic Area, Type of Service and Key Geographical...
-
TAIPEI, Taiwan, Sept. 02, 2025 (GLOBE NEWSWIRE) -- OBI Pharma, a clinical-stage oncology company (4174.TWO), today announced the initiation of a Phase 1/2 clinical trial of OBI-902, an antibody-drug...
-
A newly established global alliance integrating specialized expertise in oncology, medical imaging, patient recruitment as well as pharmacokinetics and pharmacodynamics studiesComprehensive access to...
-
Dublin, July 21, 2025 (GLOBE NEWSWIRE) -- The "Bioavailability Enhancement Technologies and Services Market Industry Trends and Global Forecasts to 2035" report has been added to ...
-
Dublin, May 27, 2025 (GLOBE NEWSWIRE) -- The "Thin Film Drug Manufacturing - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Thin...
-
Pasithea Tx' PAS-004 shows up to 91% pERK inhibition in Phase 1 trial; one pancreatic cancer patient sees 4+ months stable disease and tumor shrinkage.
-
Dublin, Jan. 24, 2025 (GLOBE NEWSWIRE) -- The "Biosimulation Market Report 2025" has been added to ResearchAndMarkets.com's offering.The biosimulation market size is forecast to see rapid growth in...